Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-04-30 | 2025-04-30 |
| Drug Identification Number | 02443287 | 02443287 |
| Brand name | NXSTAGE PUREFLOW SOLUTION RFP-207-CAN | NXSTAGE PUREFLOW SOLUTION RFP-207-CAN |
| Common or Proper name | Hemodialysis Solution | Hemodialysis Solution |
| Company Name | NXSTAGE MEDICAL INC | NXSTAGE MEDICAL INC |
| Ingredients | SODIUM CHLORIDE MAGNESIUM CHLORIDE DEXTROSE POTASSIUM CHLORIDE CALCIUM CHLORIDE SODIUM LACTATE | SODIUM CHLORIDE MAGNESIUM CHLORIDE DEXTROSE POTASSIUM CHLORIDE CALCIUM CHLORIDE SODIUM LACTATE |
| Strength(s) | 5.552G 0.102G 1.1G 0.075G 0.221G 8.408G | 5.552G 0.102G 1.1G 0.075G 0.221G 8.408G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | HAEMODIALYSIS DIALYSIS | HAEMODIALYSIS DIALYSIS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 5000 mL per bag/ Two (2) bags per shipping carton | 5000 mL per bag/ Two (2) bags per shipping carton |
| ATC code | B05ZA | B05ZA |
| ATC description | HEMODIALYTICS AND HEMOFILTRATES | HEMODIALYTICS AND HEMOFILTRATES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-08-01 | 2025-08-01 |
| Actual start date | ||
| Estimated end date | 2025-11-01 | 2025-11-01 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |